We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Positron Emission Mammography Technology Used for Novel Radiotracer Research

By MedImaging International staff writers
Posted on 25 Mar 2010
Universities in the United States are utilizing positron emission mammography (PEM) scanner technology in preclinical and translational research for the development of novel radiotracers.

Johns Hopkins Medicine (Baltimore, MD, USA) has become the latest academic medical center to acquire the Naviscan (San Diego, CA, USA) PEM scanner. The device will be utilized by Richard Wahl, M.D., F.A.C.R, professor of radiology and nuclear medicine at the Johns Hopkins University School of Medicine, in the radiotracer research.

"As the use of Naviscan's organ-specific PET [positron emission tomography] imaging technology continues to be used in cutting-edge breast cancer research and clinical patient management, Naviscan is also developing its use in new clinical applications. As a result, the development and clinical validation of novel radiotracers is essential,” said Paul J. Mirabella, chairman and CEO, Naviscan, Inc.

Dr. Wahl patented the technology that enabled Naviscan to develop the first and only U.S. Food and Drug Administration (FDA)-cleared PET-guided biopsy accessory, known as Stereo Navigator. Naviscan obtained an exclusive license to this patent, which Dr. Wahl developed while he was at the University of Michigan (Ann Arbor, USA).

Other academic medical centers utilizing Naviscan's PEM technology include University of Cincinnati, Baylor University (Waco, TX, USA), M.D. Anderson (Houston, TX, USA), University of Chicago (IL, USA), and the Boston University Medical Center (MA, USA).

Naviscan, Inc. develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiologic and surgical procedures. The Naviscan PET scanner is currently installed and available in breast and imaging centers throughout the United States and other parts of the world. The company is the first to obtain FDA clearance for a high-resolution PET scanner designed to image small body parts and for breast-biopsy image guidance.

Related Links:

Johns Hopkins Medicine Center
Naviscan


Diagnostic Ultrasound System
DC-80A
Digital X-Ray Detector Panel
Acuity G4
New
Digital Radiography System
DR-300
Multi-Use Ultrasound Table
Clinton

Channels

Imaging IT

view channel
Image: QT Imaging’s latest breast imaging software adds enhanced reflection images by combining speed-of-sound and reflection data (photo courtesy of QT Imaging)

Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases

Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.